VC Investment Memo: What investors Write

I've reviewed over 40 VC investment memos in the last quarter. Not the ones firms publish on their websites. The real ones.

I've worked with 150+ companies raising capital.

Internal documents that partners circulate, annotate, and fight over before writing a check for $5M, $15M, $50M of fund capital.

The memos that got deals done weren't the longest. They weren't the flashiest.

They were the ones where a founder had already done 80% of the memo writer's work through their deck, data room, and risk disclosures.

A VC investment memo decides your round. And the decision gets made in a room you'll never be in.

What is a VC investment memo?

After a partner meets you and says "this is interesting, let me take it to my team," the real work begins.

The partner (or their associate) sits down and writes a document for the investment committee. That document is the VC investment memo.

It's not your pitch. It's not your business plan. It's the investor's internal analysis of whether you deserve their capital, written for partners who've never met you.

Think of it this way. Your pitch deck is for the partner you met.

The VC investment memo is what that partner tells their colleagues. Everything you presented, every number you shared, every risk you disclosed (or didn't) gets distilled into 5-15 pages that the investment committee uses to vote.

That memo is the most important document in your fundraise, and you don't write it. That asymmetry should motivate you, not frustrate you.

Global startup funding hit $425 billion in 2025, a 30% year-over-year increase. Market data from Pitchbook shows that deal activity varies significantly by investor type and stage. More capital flowing in means more companies chasing it.

Investment committees are disciplined now. They're not writing large checks on vibes.

Insights from deal trends show that investor due diligence has gotten much stricter in recent years. They're writing checks on memos that hold up under pressure from other partners who've seen hundreds of memos before.

Who writes the vc investment memo and when?

At most VC firms, the person who met you writes the vc investment memo. It could be a partner or an associate who took the meeting and needs to present their thesis to the partnership.

The timing varies. Some firms write it the day after meeting you. Others wait until they've done 5-10 more coffees with founders and want to batch their IC recommendations.

A few aggressive firms write the memo before the first meeting, using intelligence from their network and press, so they can hit the ground with specific questions.

Here's what matters: the memo writing process starts immediately after your meeting ends. In that window, every email you send, every follow-up material you provide, every update you give shapes the memo.

You influence the document indirectly by influencing what the memo writer has to work with. This is where a vc deal memo begins to take shape, before your follow-up email lands.

Subscribe to our Newsletter.
Get early access to the resources we share with founders building real businesses. Subscribe to stay ahead of what's working.

The five elements VCs scan for in under 90 seconds

After watching what actually gets funded and what dies in committee, the pattern is stark.

Investment committees evaluate every vc investment memo against five things.

That last row is where most founders fail. Every vc investment memo includes a risk section.

The IC will identify risks whether you list them or not. The question is whether you've thought about them first.

I worked with a healthtech founder last year raising $12M Series A. They had:

• Smart product

• Strong user engagement.

But the deck mentioned nothing about FDA timelines, reimbursement risk, or healthcare regulatory unknowns.

The partner championing him walked into the IC meeting confident. Two other partners opened fire with questions the memo couldn't answer. They'd both been burned by healthtech regulatory delays. The committee voted no.

Compare that to a robotics founder at the same stage. First section of his vc investment memo: "Regulatory risks and mitigation."

Three years of pre-certification testing already mapped. Supply chain contingencies documented.

The IC memo practically wrote itself because the founder had done the thinking.

What structure does the VC investment memo template actually follow?

Most VC firms don't follow a single template. Bessemer has one format. a16z has another.

Sequoia has its own version too.

But the underlying structure converges across firms, even globally. Understanding that structure helps founders know what materials to provide.

A vc investment memo template that works universally doesn't exist, but the core sections do.

Here's the skeleton every memo follows, with variation in emphasis based on stage:

• The thesis (1-2 pages): Why this investment, why now, why this price. The "why now" part is critical. It connects the company's moment to what's happening in the market. Founders who nail this eliminate the biggest objection: "Why not wait six months?"

• Market opportunity (1-2 pages): TAM defined bottom-up. SAM broken down by segment. The memo writer needs to know the addressable market isn't just big. It's structurally accessible to this founder's product and distribution model.

• Company and traction (2-3 pages): Revenue or engagement metrics, cohort retention, unit economics, growth rate. This is where the memo gets specific. Real numbers from real customers. Not projections.

• Team (0.5-1 page): Founder backgrounds, why they're the right team for this problem, key hires so far and key hires planned. The IC is betting on people. This section either makes the bet feel safe or makes it feel risky.

• Competitive positioning (0.5-1 page): Who else is attacking this problem? What's different about this founder's approach? This isn't a "competition matrix." It's a narrative about why this founder will win if the market goes the way you think it will.

• Risk and mitigations (1-2 pages): Three to five genuine risks, each with likelihood, impact, and a mitigation strategy the founder has thought through. This section is where credibility either goes up or down.

• Use of capital (0.5 page): Where the money goes, tied to product roadmap and metric targets. Engineers? Sales? Operations? Why that allocation?

• The ask (0.5 page): Round size, price, who else is in the round, what's the timeline. Clean and simple.

That structure is roughly 8-15 pages for a typical Series A memo. Growth-stage memos run longer because institutional investors demand deeper analysis. Seed memos are shorter, more thesis-driven, less operationally detailed.

The takeaway for founders: your materials should map cleanly to this structure.

If a memo writer has to hunt through 40 pages of your data room to find cohort retention data, they'll move to the next deal instead of digging.

How does the investment memo template differ by investor type?

This is where many founders stumble. A Silicon Valley seed fund's investment memo template looks nothing like a growth equity firm's. A European family office expects a different memo than a Boston institutional fund.

US venture capital memos tend to be thesis-driven. "We believe this team will capture AI infrastructure for the next decade. Here's the evidence."

Partner writes a bold conviction and the IC either buys it or doesn't.

European institutional investors write memos that are mechanically detailed.

• Scenario analysis

• Sensitivity tables.

Downside cases modeled out explicitly. The memo needs to prove defensibility against five different market conditions.

Private equity investment memo structures (growth equity deals) go deeper on:

• Financial modeling

• Comparable transaction analysis

• Management team assessment.

They're evaluating buyouts and scaled growth.

Harvard's Business Law Forum discusses governance structures common in these deals. Unit economics and pathway to profitability matter more than product moonshot potential.

Middle East sovereign wealth funds and family offices often want relationship and strategic alignment sections the most. "How does this company fit our portfolio thesis?" matters more than "Is the market big?"

Those memos read like relationship documents, not pure financial analysis.

Knowing which investor you're pitching should shape what materials you provide.

A growth equity firm needs a 25-page financial model. A seed fund wants a one-pager and a deck. Give them what their memo-writing process demands, and your deal moves faster.

What actually kills a memo in the investment committee?

I want to push back on something founders assume. They think memos die because the market is wrong or the product isn't interesting enough. Usually that's not it.

Memos die when one partner asks a question in IC and the memo can't answer it. Two outcomes from there: the championing partner answers the question off the cuff, or nobody can answer it and the partnership agrees to "pass for now and revisit when more data exists."

Here are the questions that actually kill deals in a vc deal memo evaluation, and the sections that need to prevent them:

1. Why should we believe the traction is real?

The memo needs:

• Cohort data

• Unit metrics

• Not top-line revenue with no context.

A founder with $500K MRR but declining cohort retention loses credibility in committee. A founder with $200K MRR and improving cohort retention looks defensible.

2. What's the competitive risk if one of the incumbents focuses on this?

The memo needs to either dismiss incumbent risk convincingly or own it. "Salesforce could build this in six months" is a real risk.

The memo needs to explain why Salesforce won't, or why it doesn't matter if they do.

3. Have we stress-tested unit economics against lower growth?

The memo needs a sensitivity table.

• What if growth is 50% slower?

• What if CAC is 30% higher?

If unit economics break at 70% of plan, the IC will pass. They want to see margins holding even at stressed assumptions.

4. Is the team actually going to execute against this roadmap?

This is where the risk section saves you. If the founder has listed "key person risk on VP Sales" and explained the mitigation plan (two sales people reporting in, specific hiring timeline), the IC nods.

If they act like there's no key person risk, the IC assumes the team can't handle setbacks.

5. Why now? Why can't this wait?

The memo needs a "why now" that connects to market forces, not just company readiness. "We've hit product-market fit and need to scale before Series A becomes expensive" isn't a why now.

"Regulators just clarified RFP requirements for this use case, and we have six months before incumbents adapt" is.

A memo that can't answer those questions dies. A memo that answers them in the pages the IC is reading moves to the next stage.

Founders assume the pitch deck IS the memo

This is the most dangerous misconception founders carry into fundraising.

Your pitch deck is input. The VC investment memo is output. The deck gives the associate raw material.

The memo is what they construct from it. And if your deck doesn't provide the specific data the memo needs (cohort-level retention, CAC payback, risk matrix, comparable companies), then the associate either guesses or asks you for it later, which delays the process by weeks.

I reviewed a pitch deck last month for a SaaS founder raising a $5M seed. Twelve polished slides. Company overview, market size, product, team, financials, ask.

Zero cohort data. Zero CAC payback calculation. No risk section.

When I asked about CAC payback, the founder said, "I'll explain that in the meeting." But he won't be in the IC meeting. His deck will be. And his deck had nothing the memo writer could work with except a spreadsheet of annual revenue.

The memo writer faced a choice: dig into the founder's data room and construct cohort analysis (time-consuming), or write a weak memo saying "revenue is growing but retention data is incomplete."

I know which memo gets written more often.

Your pitch deck needs to be a memo-first document. That means including the metrics a memo writer needs on the traction slide: retention curves, cohort economics, CAC payback.

Not as an appendix. On the actual slide.

Founders assume one investment memo format works for all investors

I've worked across Europe, the US, and the Middle East. VC investment memo expectations vary more than most founders realize. A US venture memo might be five pages and thesis-heavy.

• A Swiss private bank's memo might be 25 pages and mathematically detailed.

• An Asian family office might want a memo that emphasizes founder character and advisor relationships.

The mistake founders make is building one data room and hoping it works everywhere. It doesn't. The structure and emphasis need to shift based on who's reading it.

If you're pitching growth equity firms (the private equity investment memo world), they want detailed unit economics, scenario modeling, and historical comparable transactions. If you're pitching US seed funds, they want a compelling thesis and early traction.

If you're pitching European institutional investors, they want bottom-up unit math and risk scenario analysis.

Knowing your investor's memo process means providing the right materials to make their job easier. Give a growth equity firm a seed-stage deck with no financial model and they'll pass. Give a seed fund a 50-page financial projection and they'll stop reading at page three.

How to structure materials for the memo writer

You can't control what gets written in a vc investment memo. But you can almost guarantee a strong one by controlling what materials the writer has to work with.

• Start with your data room.

• Organize it the way a memo writer would organize it:
  - Financials first
  - Metrics dashboard second
  - Customer stories and case studies third
  - Competitive analysis fourth
  - Risk assessment fifth.

Don't make the writer dig. Make them lift and paste.

Your pitch deck should include the metrics that matter for your stage. For guidance on which investor metrics to prioritize, focus on what changes by funding stage.

• Pre-revenue? Engagement retention and cohort behavior.

• Early revenue? MRR, churn, unit economics.

• Growth stage? ARR, NRR, CAC payback, burn multiple.

Build a risk section into your materials before the investor ever writes a memo. For each risk, document:

• Likelihood: Probability the risk materializes (low/medium/high)

• Impact: What happens if it does (low/medium/high)

• Mitigation: What you're doing to prevent or contain it

A founder who does this thinking first builds more credibility in the vc investment memo than a founder who pretends risks don't exist.

Then do something critical: include your own competitive analysis. Not a "competition matrix" (investors hate those).

An actual analysis of how your solution differs from incumbents and why you'll win if the market goes the way you expect. When the vc investment memo writer doesn't have to invent this, they use your framework instead of making something less favorable.

And finally, nail the "why now." Connect your round to what's happening in the market right now. "AI is growing" doesn't do it.

"Inference costs fell 80% in 18 months, which made our unit economics positive for the first time in Q4 2025, and we need capital to scale before larger engineering teams copy us" does.

A founder who provides clean data, honest risk assessment, and a bulletproof "why now" makes the memo nearly write itself. That's how you win.

What a working investment memo template actually includes

Here's what a working investment memo template actually looks like, based on real memos that get deals done internally in actual investment committees. A16z has also published examples of their memo structure in portfolio updates.

Memo Header (for IC routing): Company name, date, recommending partner, round size, valuation, check size, other VCs invited.

Executive Summary (1 paragraph, 100-150 words): The entire case in one paragraph. Why this company, why this price, why now. If the partner who met you can't explain your deal to the IC in one paragraph, the memo is already in trouble.

The Thesis (1 page): "We believe [founder] will build the [market segment] software that [solves X problem] better than [incumbents] because [defensible advantage]. The market is moving in our direction because [macro force]. We're investing at [price] because [valuation logic]."

Market Opportunity (1 page): TAM defined with bottom-up research, not top-down bluster. SAM broken down by initial target segment. Why this team can win in this segment.

Traction (1-2 pages): Revenue or engagement metrics by cohort. Growth rate month-over-month and year-over-year. Retention curves, CAC, payback, gross margins. Every number has a source: "From their financial model," "From customer interviews," or "From their data warehouse."

Team (0.5 pages): Founder background, relevant wins, pattern recognition. Why they specifically will win. Key hires so far and key hires planned.

Competitive Positioning (0.5 pages): Who else is attacking this problem? Why this founder wins? What changes if an incumbent focuses on this space?

Risk Assessment (1 page): Three to five risks listed explicitly. For each: probability (%), impact (%), mitigation. Examples: "Founder leaves before product-market fit" or "Regulatory changes make unit economics unviable" or "Incumbent launches competitive product."

Use of Capital (0.5 pages): Hiring plan tied to milestones. How many engineers? Sales people? What metrics do you expect to hit with this capital?

Investment Recommendation (0.5 pages): "I recommend we lead this round at [price] for [stake]. Next steps: founder meeting with [other partners], legal review, signing."

That structure, roughly 3-5 pages total and sometimes 8-10 for larger rounds, is what gets voted on. Anything else is filler.

How private equity investment memo structures differ

If you're raising growth equity, the VC investment memo process works differently. McKinsey's research on PE fund performance shows how detailed memo writing contributes to better outcomes. Growth equity and buyout firms write much longer documents because the stakes are higher and the diligence bar is stricter.

A private equity investment memo template includes all the VC elements plus: detailed historical financial analysis (5-year revenue CAGR, gross margin trends, SG&A as percentage of revenue), sensitivity tables showing returns under different growth scenarios, comparable transaction analysis (what do similar companies trade at?). Carta's data on startup valuations and cap tables informs many of these analyses.

Management team assessment (can they execute, or do we need to bring in someone?), and detailed operational plans for the first 100 days post-investment.

PE memos also spend more time on exit scenarios: "If growth hits 30%, we exit at 8x revenue. If growth misses 15%, we exit at 5x revenue." Bain's data on exit multiples guides these assumptions.

In both cases, they model 3-4x cash returns. The memo is financially engineered, not just conceptually sound.

If you're pitching growth equity firms, provide historical financials for 3-5 years.

Model out scenarios for the next 3-5 years, showing what happens if growth is 30% slower or 30% faster. That's what their memo-writing process demands.

My direct assessment

I've built capital raising processes for hundreds of founders and watched what actually gets funded. Here's what I believe most founders don't understand about the memo.

It is the most important document in your fundraise, and you will never be in the room when it's discussed.

That asymmetry frustrates founders. It should motivate them instead. Every piece of material you produce, your deck, your data room, your financial model, your risk analysis, exists to make that memo stronger.

If you approach fundraising with that lens, everything changes.

Stop thinking about your materials as presentation tools. Start thinking about them as memo fuel. The founder who does this consistently doesn't just raise faster. They raise on better terms, because the memo reads like a conviction bet, not a coin flip.

The median Series B in 2026 is $68 million, per Crunchbase. Learn more about preparing for Series B rounds where memo scrutiny intensifies. At those numbers, the memo gets poured over like legal documents.

Partners aren't writing $68M checks on weak analysis. They're writing them on memos that hold up under pressure.

Build your materials to withstand that pressure, and the capital follows.

How spectup helps

After running capital raises across our client portfolio, the pattern is consistent: founders spend weeks on pitch delivery and almost no time thinking about what the memo writer needs.

An associate takes the meeting. They go back to their desk with your deck, your data, your story.

Now they need to write a memo that survives the IC. If your materials don't give them the risk framework, the unit economic proof, and the "why now" thesis in a form they can lift directly, the memo stalls.

That's where most deals quietly die.

We solve that by building materials with the IC vc investment memo in mind from day one. We stress-test every claim, every metric, every risk disclosure against what actually kills memos in committee.

Our approach focuses on three things:

• Scenario tables: Financial modeling that memo writers can paste directly into their internal documents

• Data-first decks: Pitch deck design that prioritizes the metrics a memo needs, not just what looks good on screen

• Risk frameworks: Honest risk assessment that builds founder credibility in the IC

Our financial modeling work ensures memos have the numbers they need. Our pitch deck design puts data first.

If you're six to twelve months from your next round and want the memo to write itself, book a call with me.